Tiny Blood Vessels May Help the Heart Build Natural Bypasses After a Heart Attack
Tekstas jau gerai sudėliotas, bet keliose vietose formuluotės buvo kiek per kategoriškos gyvūnų tyrimui. Paredagavau išlaikydama visus faktus, skaičius ir informacijos eiliškumą.
After a heart attack, a blocked coronary artery deprives part of the heart muscle of oxygen and nutrients, often causing irreversible damage. Doctors know that the body attempts emergency repairs by enlarging existing vessels or growing new ones, but these natural responses are usually too slow or incomplete to prevent scarring.
A new study led by scientists at the University of Chinese Academy of Sciences reveals a previously underappreciated repair pathway involving tiny capillaries. Rather than major arteries doing most of the work, the smallest blood vessels appear capable of remodeling into artery-like channels that help restore blood flow.
Capillaries step in as backup routes
The research team used advanced cell-tracking techniques in mouse models of heart attack to follow endothelial cells, which line blood vessels, in real time. Contrary to previous assumptions, they found that capillary endothelial cells were the main source of new collateral vessels that bypassed the blockage.
These capillaries effectively “upgrade” themselves, thickening and reorganizing into higher-capacity conduits that resemble small arteries. The process mirrors how the coronary circulation develops in newborn mice, when capillaries coalesce to form early arterial branches as the heart grows.
By redefining the cellular origin of these collateral vessels, the study identifies capillary arterialization as an important natural mechanism of heart repair. This new understanding could redirect efforts toward stimulating the right cells at the right time after an infarction.
Boosting natural bypass growth with VEGF
To test whether this backup system could be enhanced, the scientists focused on VEGF-A, a signaling protein known to promote blood vessel growth. They delivered carefully controlled, short pulses of VEGF-A to mice after experimental heart attacks and monitored the effects on vessel remodeling.
The treatment triggered molecular signals that strengthened and stabilized the nascent bypass vessels formed from capillaries. Mice receiving the optimized VEGF-A regimen showed improved blood flow around the injured region, smaller scarred areas, and better overall heart function compared with untreated animals.
The authors note that excessive or prolonged VEGF-A can cause leaky or abnormal vessels, making timing and dose critical. Their results suggest that moderate, targeted supplementation may restore microcirculatory function while avoiding some of the drawbacks seen with earlier, less refined approaches.
Implications for human heart attack care
The findings are based on animal experiments, so whether the same approach would benefit humans remains to be established. However, researchers suspect that a comparable capillary-driven repair program may operate in people following heart injury.
In many countries, including the United States, more than 90 percent of hospitalized heart attack patients now survive the acute event. Yet many are left with weakened hearts and an elevated risk of heart failure and arrhythmias, driven largely by permanent scarring and reduced blood supply.
If future therapies can safely accelerate capillary arterialization immediately after a heart attack, they might help limit tissue death, reduce scar formation, and preserve long-term pumping function. Such treatments could potentially complement existing procedures such as angioplasty and stenting that reopen blocked arteries.
The study also underscores a broader trend in cardiology: harnessing the body’s own repair programs rather than relying solely on mechanical interventions. By mapping how microvessels respond to injury in precise detail, scientists hope to design treatments that steer these natural processes toward more effective healing.
The research was published in the journal Science and adds to a growing body of work on collateral circulation and regenerative strategies for ischemic heart disease. While many hurdles remain before any human therapy emerges, the discovery of a capillary-based bypass system offers a promising new target for limiting heart damage after an infarction.
